Expression of bone sialoprotein in mineralized tissues of tooth and bone and in buccal-pouch carcinomas of syrian golden hamsters

Archives of Oral Biology

Volumn 45, Issue 7, 2000, Pages 551-562

  Sasaguri, K ^a   Ganss, B ^b   Sodek, J ^b   Chen, J K ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone sialoprotein; Carcinogenesis; Gene expression; Hamster; Squamous cell carcinoma

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; BONE SIALOPROTEIN; CARCINOGEN; SIALOGLYCOPROTEIN; SIALOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE; BONE MINERALIZATION; CELL TRANSFORMATION; CHEEK; CHEEK POUCH; COMPARATIVE STUDY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; IATROGENIC DISEASE; IN SITU HYBRIDIZATION; MALE; METABOLISM; MOLECULAR GENETICS; MOUTH CARCINOMA; MOUTH MUCOSA; MOUTH TUMOR; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RANDOMIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SYRIAN HAMSTER; TOOTH; TOOTH DEVELOPMENT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BONE AND BONES; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CHEEK; CRICETINAE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MALE; MESOCRICETUS; MOLECULAR SEQUENCE DATA; MOUTH MUCOSA; MOUTH NEOPLASMS; RANDOM ALLOCATION; SIALOGLYCOPROTEINS; TOOTH;

ANIMALIA; CRICETINAE; MAMMALIA; MESOCRICETUS AURATUS;

EID: 0034041269     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9969(00)00022-4     Document Type: Article

References (44)

1. Arzate H., Olson S.W., Page R.C., Narayanan A.S. Isolation of human tumour cells that produce cementum proteins in culture. Bone & Mineral. 18:(1):1992;15-30.
2. Aznavoorian S., Murphy A.N., Stetler Stevenson W.G., Liotta L.A. Molecular aspects of tumour cell invasion and metastasis. Cancer. 71:(4):1993;1368-1383.
3. Bellahcene A., Antoine N., Clausse N., Tagliabue E., Fisher L.W., Kerr J.M., Jares P., Castronovo V. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels. Laboratory Investigation. 75:(2):1996;203-210.
4. Bellahcene A., Castronovo V. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases. Bulletin du Cancer. 84:(1):1997;17-24.
5. Bellahcene A., Kroll M., Liebens F., Castronovo V. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. Journal of Bone & Mineral Research. 11:(5):1996;665-670.
6. Bellahcene A., Maloujahmoum N., Fisher L.W., Pastorino H., Tagliabue E., Menard S., Castronovo V. Expression of bone sialoprotein in human lung cancer. Calcified Tissue International. 61:(3):1997;183-188.
7. Bellahcene A., Menard S., Bufalino R., Moreau L., Castronovo V. Expression of bone sialoprotein in primary human breast cancer is associated with poor survival. International Journal of Cancer. 69:(4):1996;350-353.
8. Bellahcene A., Merville M.P., Castronovo V. Expression of bone sialoprotein, a bone matrix protein, in human breast cancer. Cancer Research. 54:(11):1994;2823-2826.
9. Bosse A., Wuisman P., Jones D.B., Schwarz K. Noncollagenous proteins in heterotopic ossification. Immunohistochemical analysis in 15 paraplegics. Acta Orthopaedica Scandinavica. 64:1993;634-638.
10. Butler W., Ridall A., McKee M. Bilezikian J., Raisz L.G., Rodan G. Osteopontin. Principles of bone bilogy. 1996;167-181 Academic Press, San Diego.
11. Castronovo V., Bellahcene A. Evidence that breast cancer associated microcalcifications are mineralized malignant cells. International Journal of Oncology. 12:(2):1998;305-308.
12. Chen J., Aufdemorte T.B., Jiang H., Liu A.R., Zhang W., Thomas H.F. Neoplastic odontogenic epithelial cells express bone sialoprotein. Histochemical Journal. 30:(1):1998;1-6.
13. Chen J., Shapiro H.S., Sodek J. Development expression of bone sialoprotein mRNA in rat mineralized connective tissues. Journal of Bone Mineral Research. 7:(8):1992;987-997.
14. Chen J., Thomas H.F., Jin H., Jiang H., Sodek J. Expression of rat bone sialoprotein promoter in transgenic mice. Journal of Bone Mineral Research. 11:(5):1996;654-664.
15. Chen J.J., Jin H., Ranly D.M., Sodek J., Boyan B.D. Altered expression of bone sialoproteins in vitamin D-deficient rBSP2.7Luc transgenic mice. Journal of Bone Mineral Research. 14:(2):1999;221-229.
16. Chenu C., Colucci S., Grano M., Zigrino P., Barattolo R., Zambonin G., Baldini N., Vergnaud P., Delmas P.D., Zallone A.Z. Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. Journal of Cell Biology. 127:(4):1994;1149-1158.
17. Craig A.M., Smith J.H., Denhardt D.T. Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. Journal of Biological Chemistry. 264:(16):1989;9682-9689.
18. Fisher L.W., McBride O.W., Termine J.D., Young M.F. Human bone sialoprotein. Deduced protein sequence and chromosomal localization. Journal of Biological Chemistry. 265:(4):1990;2347-2351.
19. Ganss, B., Kim, R.H., Sodek, J., 2000. Bone sialoprotein, Critical Reviews of Oral Biology and Medicine (in press).
20. Grano M., Zigrino P., Colucci S., Zambonin G., Trusolino L., Serra M., Baldini N., Teti A., Marchisio P.C., Zallone A.Z. Adhesion properties and integrin expression of cultured human osteoclast-like cells. Experimental Cell Research. 212:(2):1994;209-218.
21. Hirota S., Ito A., Nagoshi J., Takeda M., Kurata A., Takatsuka Y., Kohri K., Nomura S., Kitamura Y. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci. Laboratory Investigation. 72:(1):1995;64-69.
22. Hunter G.K., Goldberg H.A. Nucleation of hydroxyapatite by bone sialoprotein. Proceedings of the National Academy of Sciences of the United States of America. 90:(18):1993;8562-8565.
23. Kim R.H., Sodek J. Transcription of the bone sialoprotein gene is stimulated by v-Src acting through an inverted CCAAT box. Cancer Research. 59:(3):1999;565-571.
24. Lane T.F., Sage E.H. The biology of SPARC, a protein that modulates cell-matrix interactions. Faseb Journal. 8:(2):1994;163-173.
25. Ledda M.F., Adris S., Bravo A.I., Kairiyama C., Bover L., Chernajovsky Y., Mordoh J., Podhajcer O.L. Suppression of SPARC expression by antisense RNA abrogates the tumourigenicity of human melanoma cells. Nature Medicine. 3:(2):1997;171-176.
26. Midura R.J., McQuillan D.J., Benham K.J., Fisher L.W., Hascall V.C. A rat osteogenic cell line (UMR 106-01) synthesizes a highly sulfated form of bone sialoprotein. Journal of Biological Chemistry. 265:(9):1990;5285-5291.
27. Miyauchi A., Alvarez J., Greenfield E.M., Teti A., Grano M., Colucci S., Zambonin-Zallone A., Ross F.P., Teitelbaum S.L., Cheresh D., et al. Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. Journal of Biological Chemistry. 266:(30):1991;20,369-20,374.
28. Oates A.J., Barraclough R., Rudland P.S. The role of osteopontin in tumourigenesis and metastasis. Invasion & Metastasis. 17:(1):1997;1-15.
29. Oldberg A., Franzen A., Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proceedings of the National Academy of Sciences of the United States of America. 83:(23):1986;8819-8823.
30. Oldberg A., Franzen A., Heinegard D. The primary structure of a cell-binding bone sialoprotein. Journal of Biological Chemistry. 263:(36):1988;19,430-19,432.
31. Oldberg A., Franzen A., Heinegard D., Pierschbacher M., Ruoslahti E. Identification of a bone sialoprotein receptor in osteosarcoma cells. Journal of Biological Chemistry. 263:(36):1988;19,433-19,436.
32. Porter P.L., Sage E.H., Lane T.F., Funk S.E., Gown A.M. Distribution of SPARC in normal and neoplastic human tissue. Journal of Histochemistry and Cytochemistry. 43:(8):1995;791-800.
33. Ross F.P., Chappel J., Alvarez J.I., Sander D., Butler W.T., Farach-Carson M.C., Mintz K.A., Robey P.G., Teitelbaum S.L., Cheresh D.A. Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. Journal of Biological Chemistry. 268:(13):1993;9901-9907.
34. Sage E.H. Terms of attachment: SPARC and tumourigenesis [news]. Nature, Medicine. 3:(2):1997;144-146.
35. Sasaguri K., Jiang H., Chen J. The effect of altered functional forces on the expression of bone-matrix proteins in developing mouse mandibular condyle. Archives of Oral Biology. 43:(1):1998;83-92.
36. Senger D.R., Perruzzi C.A., Papadopoulos A. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Research. 9:(5):1989;1291-1299.
37. Sodek J., Kasugai S., Nagata T., Zhang Q., McKee M.D., Nance A. Slavkin h P.P. Elucidating the functions of bone sialoprotein and osteopontin in bone formation. Chemistry and biology of mineralized tissues. 1992;297-306 Elsevier, Amsterdam.
38. Solt D.B., Shklar G. Rapid induction of gamma-glutamyl transpeptidase-rich intraepithelial clones in 7,12-dimethylbenz(a)anthracene-treated hamster buccal pouch. Cancer Research. 42:(1):1982;285-291.
39. Somerman M.J., Fisher L.W., Foster R.A., Sauk J.J. Human bone sialoprotein I and II enhance fibroblast attachment in vitro. Calcified Tissue International. 43:(1):1988;50-53.
40. Stewart J.F., King R.J., Sexton S.A., Millis R.R., Rubens R.D., Hayward J.L. Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. European Journal of Cancer. 17:(4):1981;449-453.
41. Sung V., Stubbs J.Tr, Fisher L., Aaron A.D., Thompson E.W. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins. Journal of Cell Physiology. 176:(3):1998;482-494.
42. van der Pluijm G., Vloedgraven H.J., Ivanov B., Robey F.A., Grzesik W.J., Robey P.G., Papapoulos S.E., Lowik C.W. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Research. 56:(8):1996;1948-1955.
43. Waltregny D., Bellahcene A., Van Riet I., Fisher L.W., Young M., Fernandez P., Dewe W., de Leval J., Castronovo V. Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. Journal of National Cancer Institute. 90:(13):1998;1000-1008.
44. Yura Y., Harada K., Tsujimoto H., Yoshida H., Sato M. Effects of sialoadenectomy and epidermal growth factor administration on 9,10-dimethyl-1,2-benzanthracene-induced tumour formation in hamster cheek pouch. Oral Surgery Oral Medicine Oral Pathology. 76:(6):1993;723-728.